CME credit expires: April 1, 2018. If this date has passed, please contact NEI for updated information.
These case-based questions, divided into 10 core areas of psychiatry, will help you identify areas in which you need further study. Each question is followed by an explanation of the answer choices and a list of references.
This activity has been developed for prescribers specializing in psychiatry. There are no prerequisites. All other health care providers interested in psychopharmacology are welcome for advanced study, especially primary care physicians, nurse practitioners, psychologists, and pharmacists.
Statement of need
Mental disorders are highly prevalent and carry substantial burden that can be alleviated through treatment; unfortunately, many patients with mental disorders do not receive treatment or receive suboptimal treatment. There is a documented gap between evidence-based practice guidelines and actual care in clinical practice for patients with mental illnesses. This gap is due at least in part to lack of clinician confidence and knowledge in terms of appropriate usage of the diagnostic and treatment tools available to them.
To help fill these unmet needs, quality improvement efforts need to provide education regarding: (1) diagnostic strategies that can aid in the identification and differential diagnosis of patients with psychiatric illness; (2) effective clinical strategies for monitoring and treating psychiatric patients; (3) new scientific evidence that is most likely to affect clinical practice and neurobiological and
pharmacological research; and (4) strategies to optimize functional outcomes for patients with psychiatric illnesses, including strategies to monitor and maximize adherence and working with patients to set and track recovery-oriented goals.
After completing the entire book, Stahl’s Self-Assessments in Psychiatry: Multiple Choice Questions for Clinicians, second edition
, you should be better able to:
• Diagnose patients presenting with psychiatric symptoms using accepted diagnostic standards and practices
• Implement evidence-based psychiatric treatment strategies that are aligned with the patient’s recovery goals
• Integrate recent advances in diagnostic and treatment strategies into clinical practice according to best practice guidelines
Accreditation and credit designation statements
The Neuroscience Education Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Neuroscience Education Institute designates this enduring material for a maximum of 14.0 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Society for the Advancement of Pharmacotherapy (ASAP), Division 55 of the American Psychological Association, is approved by the American Psychological Association to sponsor continuing education for psychologists. ASAP maintains responsibility for this program and its content.
The American Society for the Advancement of Pharmacotherapy designates this program for 14.0 CE credits for psychologists.
Nurses: for all of your CNE requirements for recertification, the ANCC will accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. The content of this activity pertains to pharmacology and is worth 14.0 continuing education hours of pharmacotherapeutics.
Physician Assistants: the NCCPA accepts AMA PRA Category 1 Credit ™ from organizations accredited by the AMA (providers accredited by the ACCME).
A certificate of participation for completing this activity will also be available.
Please note: the content of this print monograph also exists as an online learning activity under the title “Master Psychopharmacology Program Self-Assessments, 2015–2017 edition”. If you received CME credit for that activity, you will not be able to receive credit again for completing this print monograph.
ABPN – Maintenance of certification (MOC)
The American Board of Psychiatry and Neurology (ABPN) has reviewed Stahl’s Self-Assessments in Psychiatry: Multiple Choice Questions for Clinicians, second edition, and has approved this program as part of a comprehensive lifelong learning and self-assessment program, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of maintenance of certification.
The chapters of this book can be completed in any order. You are advised to read each question carefully, formulate an answer, and then review the answer/explanation on the following page. The estimated time for completion of the entire activity (including optional posttests and CME evaluations) is 14.0 hours.
Optional posttests with CME credits are available for a fee (waived for NEI Members). For participant ease, each chapter has its own posttest and certificate. NOTE: the book as a whole is considered a single activity and credits earned must be totaled and submitted as such to other organizations. To receive a certificate of CME credit or participation, complete the chapter posttest and evaluation, available only online at neiglobal.com/CME
(under “Book”). If a score of 70% or more is attained, you will be able to immediately print your certificate. If you have questions, call 888–535–5600, or email firstname.lastname@example.org
These materials have been peer-reviewed to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. The Neuroscience Education Institute takes responsibility for the content, quality, and scientific integrity of this CME activity.
It is the policy of NEI to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. Therefore, all individuals in a position to influence or control content are required to disclose any financial relationships. Although potential conflicts of interest are identified and resolved prior to the activity being presented, it remains for the participant to determine whether outside interests reflect a possible bias in either the exposition or the conclusions presented.
Disclosed financial relationships with conflicts of interest have been reviewed by the Neuroscience Education Institute CME Advisory Board Chair and resolved.
Director, Content Development, Neuroscience Education Institute, Carlsbad, CA
No financial relationships to disclose.
Debbi Ann Morrissette, PhD
Adjunct Professor, Biological Sciences, Palomar College, San Marcos, CA
Senior Medical Writer, Neuroscience Education Institute, Carlsbad, CA
No financial relationships to disclose.
(also content editor)
Stephen M. Stahl, MD, PhD
Adjunct Professor, Department of Psychiatry, University of California, San Diego School of Medicine, San Diego, CA
Honorary Visiting Senior Fellow, University of Cambridge, UK
Director of Psychopharmacology, California Department of State Hospitals, CA
Grant/Research: Alkermes, Clintara, Forest, Forum, Genomind, JayMac, Jazz, Lilly, Merck, Novartis, Otsuka America, Pamlab, Pfizer, Servier, Shire, Sprout, Sunovion, Sunovion UK, Takeda, Teva, Tonix
Consultant/Advisor: Acadia, BioMarin, Forum/EnVivo, Jazz, Orexigen, Otsuka America, Pamlab, Servier, Shire, Sprout, Taisho, Takeda, Trius
Speakers Bureau: Forum, Servier, Sunovion UK, Takeda
Board Member: BioMarin, Forum/EnVivo, Genomind, Lundbeck, Otsuka America, RCT Logic, Shire
Ronnie Gorman Swift, MD
Professor and Associate Chairman, Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY
Chief of Psychiatry and Associate Medical Director, Metropolitan Hospital Center, New York, NY
No financial relationships to disclose.
Disclosure of off-label use
This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses.
Participants have an implied responsibility to use the newly acquired information from this activity to enhance patient outcomes and their own professional development. The information presented in this educational activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this educational activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Primary references and full prescribing information should be consulted.
Cultural and linguistic competency
This CME activity is provided by the Neuroscience Education Institute.
Additionally provided by the American Society for the Advancement of Pharmacotherapy.
This activity is supported solely by the Neuroscience Education Institute.